Shampa Mallick

Title: Shampa Mallick: Innovator in Cancer Research

Introduction

Shampa Mallick is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of cancer research, particularly through her innovative work on peptides. Her dedication to advancing medical science has led to the development of a novel anti-cancer drug.

Latest Patents

Shampa Mallick holds a patent for a "High affinity bivalent helically constrained peptide against cancer." This invention describes a unique bivalent helically constrained peptide that targets S100B, which is known to be over-expressed in certain cancers. The peptide induces rapid apoptosis in cancer cells by inhibiting key growth pathways, including the activation of p53. This groundbreaking work has the potential to provide effective treatment options for patients suffering from cancers that over-express S100B.

Career Highlights

Shampa is affiliated with the Council of Scientific and Industrial Research, where she continues to pursue her research interests. Her work has garnered attention for its innovative approach to tackling cancer, showcasing her commitment to improving patient outcomes through scientific advancements.

Collaborations

Shampa has collaborated with notable colleagues, including Amlanjyoti Dhar and Israr Ahmed. These partnerships have enriched her research and contributed to the development of her patented innovations.

Conclusion

Shampa Mallick's contributions to cancer research through her innovative peptide technology highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds promise for future cancer therapies.